BEAR Implant
Miach Orthopaedics Secures $20 Million Funding Boost in Series B Extension
Financing will enable Miach Orthopaedics continued growth of their commercial organization in the U.S., as well as support clinical initiatives like the Bridge Registry to provide important data on real-world patient outcomes.
Miach Orthopaedics Initiates Post-Market Study for BEAR® Implant
Miach Orthopedics initiated BEAR III to continue to build upon the extensive base of evidence for the BEAR Implant, which recently received De Novo approval from the U.S. Food and Drug Administration.
